NCT05138835 is a NA clinical trial of Botox Cosmetic in Oily Skin, sponsored by Andreas Nikolis.

Who is sponsoring NCT05138835?

NCT05138835 is sponsored by Andreas Nikolis.

What drugs are being tested in NCT05138835?

Interventions in NCT05138835: Botox Cosmetic.

Is NCT05138835 still recruiting?

NCT05138835 is currently completed. Last updated 31 May 2023.

Last reviewed 2023-05-31 · How we verify

NCT05138835

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

BOTOX® Cosmetic and Skin Health.

Completed NA Last updated 31 May 2023

What this trial tests

NA trial testing Botox Cosmetic in Oily Skin in 34 participants. Completed in 11 December 2022.

Timeline

11 November 2021

Primary endpoint
11 November 2022

11 December 2022

Quick facts

Lead sponsor	Andreas Nikolis
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	34
Start date	11 November 2021
Primary completion	11 November 2022
Estimated completion	11 December 2022
Sites	1 location across Canada

Drugs / interventions tested

Botox Cosmetic

Conditions studied

Oily Skin — all drugs for Oily Skin →

Sponsor

Andreas Nikolis

Who can join

18 and older, female only, with Oily Skin. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a two cohort, randomized, double blind, single center study to evaluate the effects of Botox Cosmetic (BTX) on sebum protection. Thirty-four female subjects with moderate-to-high skin sebum concentration will be recruited and randomized in a 1:1 ratio to treatment groups.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05138835 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Andreas Nikolis
Last refreshed: 31 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05138835.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing